- Home
- ATRA vs VRCA Comparison
ATRA vs VRCA Comparison
Compare ATRA & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- VRCA
- Stock Information
- Founded
- ATRA 2012
- VRCA 2013
- Country
- ATRA United States
- VRCA United States
- Employees
- ATRA N/A
- VRCA N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- ATRA Health Care
- VRCA Health Care
- Exchange
- ATRA Nasdaq
- VRCA Nasdaq
- Market Cap
- ATRA 42.9M
- VRCA 43.0M
- IPO Year
- ATRA 2014
- VRCA 2018
- Fundamental
- Price
- ATRA $7.27
- VRCA $0.44
- Analyst Decision
- ATRA Buy
- VRCA Hold
- Analyst Count
- ATRA 5
- VRCA 5
- Target Price
- ATRA $17.75
- VRCA $6.00
- AVG Volume (30 Days)
- ATRA 45.5K
- VRCA 237.2K
- Earning Date
- ATRA 05-20-2025
- VRCA 05-13-2025
- Dividend Yield
- ATRA N/A
- VRCA N/A
- EPS Growth
- ATRA N/A
- VRCA N/A
- EPS
- ATRA N/A
- VRCA N/A
- Revenue
- ATRA $128,940,000.00
- VRCA $7,566,000.00
- Revenue This Year
- ATRA N/A
- VRCA $127.58
- Revenue Next Year
- ATRA N/A
- VRCA $88.06
- P/E Ratio
- ATRA N/A
- VRCA N/A
- Revenue Growth
- ATRA 1404.02
- VRCA 47.66
- 52 Week Low
- ATRA $5.01
- VRCA $0.38
- 52 Week High
- ATRA $18.71
- VRCA $11.41
- Technical
- Relative Strength Index (RSI)
- ATRA 53.01
- VRCA 44.12
- Support Level
- ATRA $6.90
- VRCA $0.39
- Resistance Level
- ATRA $8.65
- VRCA $0.48
- Average True Range (ATR)
- ATRA 0.63
- VRCA 0.05
- MACD
- ATRA 0.03
- VRCA -0.00
- Stochastic Oscillator
- ATRA 44.58
- VRCA 44.95
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.